Increased acetylcholine availability in the synaptic cleft enhances synaptic plasticitythe brain's ability to form new neural connections and adapt to new information
GLP-1 RAs (e.g., exenatide, liraglutide, semaglutide) are incretin mimetics originally developed for type 2 diabetes
Gault VA, Kerr BD, Harriott P, Flatt PR
Nevertheless, definitive recommendations remain premature, and future trials should address optimal dosing, long-term safety, population-specific responses, and combined supplementation strategies
Do not inject where the skin is tender, bruised, scaly or hard, or into scars or damaged skin
Rights and permissions About this article Cite this article Dwivedi, D., Megha, K., Mishra, R